Serina Therapeutics SER Balance Sheet (2017-2026)

NYSE SER
$1.51 +0.08 (+5.59%)
As of: Nov 11, 2026 · 3:59 PM EST
Reported Financials

Serina Therapeutics Quarterly Balance Sheet

Periods 35 quarters
Latest Jun 2026

Serina Therapeutics reported total assets of $0.03B and total liabilities of $0.01B for the quarter ended Jun 2026, up 188.7% year over year. This balance sheet covers 35 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
0.73M0.60M0.45M0.70M0.47M0.65M0.28M0.26M0.40M7.62M8.71M6.10M3.20M3.67M4.30M6.04M8.62M3.06M24.53M23.02M
Short-term InvestmentsInvestments (Current)
10,000,000.00M
Cash & Current Investments
0.73M0.60M0.45M0.70M0.47M0.65M0.28M10,000,000.26M0.40M7.62M8.71M6.10M3.20M3.67M4.30M6.04M8.62M3.06M24.53M23.02M
Receivables - NetNet Receivables
0.02M0.03M0.01M0.00M0.00M0.01M0.01M0.07M0.06M0.07M
Receivables - OtherOther Receivables
280,000.00M280,000.00M280,000.00M0.00M0.05M0.01M
Receivables
0.02M0.03M280,000.01M0.00M0.00M0.01M280,000.01M0.07M0.06M0.07M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
0.72M1.63M1.38M1.01M0.72M1.80M1.46M1.08M0.67M0.17M2.80M2.22M2.00M1.49M1.95M2.88M3.02M1.95M2.01M
Current Assets
1.48M2.23M1.83M1.73M1.19M2.45M1.75M1.35M1.14M7.62M8.94M8.92M5.42M5.68M5.75M7.99M11.50M6.08M26.47M25.03M
Non-Current Assets
Construction in Progress
Property, Plant & Equipment (Net)PP&E (Net)
0.57M0.56M0.54M0.52M0.50M0.48M0.59M0.58M0.47M0.47M0.48M
Intangibles
0.90M0.87M0.84M0.80M0.77M0.74M0.71M0.67M0.64M0.57M0.54M0.51M
Goodwill & Intangibles
0.90M0.87M0.84M0.80M0.77M0.74M0.71M0.67M0.64M0.57M0.54M0.51M
Long-Term Deferred Tax
Other Non-Current Assets
0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.38M0.41M0.36M0.02M0.03M0.03M0.03M
Non-Current Assets
0.95M0.92M0.89M0.85M0.82M0.79M10.78M10.93M11.07M1.35M1.92M1.79M2.01M1.05M0.98M0.95M0.92M0.87M0.83M0.78M
Assets
2.43M3.15M2.72M2.58M2.01M3.24M12.53M12.28M12.21M8.97M10.86M10.71M7.44M6.72M6.73M8.94M12.41M6.95M27.30M25.81M
Liabilities
Current Liabilities
Accounts Payables
0.92M0.77M1.10M0.68M0.79M1.03M1.26M0.96M1.67M0.58M4.01M1.97M1.70M0.74M1.19M1.71M2.73M1.93M2.83M1.86M
Payables
0.92M0.77M1.10M0.68M0.79M1.03M1.26M0.96M1.67M0.58M4.01M1.97M1.70M0.74M1.19M1.71M2.73M1.93M2.83M1.86M
Accumulated Expenses
0.00M0.37M0.66M0.33M0.00M0.27M0.36M0.26M0.29M0.58M1.30M0.32M1.16M1.43M0.98M1.31M1.14M1.21M1.51M1.36M
Other Accumulated Expenses
0.07M0.07M0.07M0.07M0.06M0.14M0.14M0.23M0.25M0.07M0.01M0.20M0.19M0.19M0.55M0.35M0.34M0.46M0.55M
Short term Debt
7.14M6.97M7.30M7.65M20.04M22.94M1.53M9.75M10.45M10.46M2.89M
Current Leases
-0.01M-0.02M-0.04M0.04M0.02M0.01M-0.03M-0.04M
Current Taxes
0.15M
Current Deferred Revenue
Current Deferred Tax LiabilityCurrent Deferred Tax
Total Current Liabilities
6.60M8.97M10.10M9.09M8.81M10.08M22.53M24.51M3.20M1.41M14.06M12.63M13.51M2.37M2.35M3.56M8.79M3.56M6.34M3.76M
Non-Current Liabilities
Capital Leases
0.00M
Non-Current Debt
6.06M6.76M8.35M10.48M10.01M10.07M0.69M0.69M0.69M0.69M
Convertible Debt
2.98M2.89M2.95M3.01M3.09M
Non-Current Deferred Revenue
Preferred Stock Liabilities
0.20M35.96M36.40M
Minority Interest
-0.04M-0.04M-0.04M-0.04M-0.05M-0.10M-0.11M-0.12M-0.11M36.40M-0.03M-0.05M-0.13M-0.14M-0.16M-0.17M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
Operating Leases
0.46M0.41M0.36M0.31M0.27M0.23M0.19M0.15M0.20M0.16M0.12M
Other Non-Current Liabilities
5.81M6.06M5.82M7.79M0.66M0.18M0.35M24.08M13.41M6.74M3.58M2.59M3.55M1.68M0.09M
Total Non-Current Liabilities
6.60M8.97M8.48M8.05M16.50M40.84M48.30M41.26M15.17M13.69M14.52M2.63M2.58M3.75M8.98M6.90M9.67M7.08M
Total Liabilities
12.41M15.03M14.31M15.84M17.16M41.02M48.65M47.56M45.56M41.26M39.24M27.10M21.26M6.22M5.17M7.30M10.65M6.99M9.67M7.08M
Shareholder's Equity
Total Debt
13.20M15,000,000.00M13.72M15.65M18.12M30.05M33.01M2.22M10.44M11.14M11.16M2.89M
Common Equity
-9.98M-11.88M-11.59M-13.26M-15.15M-37.78M-36.12M-35.29M-33.35M-32.29M-28.39M-16.39M-13.83M0.51M1.56M1.65M1.76M-0.04M17.63M18.73M
Liabilities and Shareholders Equity
2.43M3.15M2.72M2.58M2.01M3.24M12.53M12.28M12.21M8.97M10.86M10.71M7.44M6.72M6.73M8.94M12.41M6.95M27.30M25.81M
Retained Earnings
-103.60M-105.75M-108.50M-111.07M-113.51M-116.21M-119.50M-122.20M-127.60M-33.18M-48.19M-42.99M-41.58M-44.32M-49.13M-55.58M-60.16M-63.50M-70.40M-76.75M
Preferred Shares
4.94M4.94M4.94M4.94M

Serina Therapeutics Balance Sheet API

Pull Serina Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SER&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY